BGI Genomics Co., Ltd. — Investor Relations & Filings
BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 国浩律师（深圳）事务所关于深圳华大基因股份有限公司二〇二四年年度股东会之法律意见书 | 2025-05-20 | Chinese | |
| 关于召开2024年年度股东会的提示性公告 | 2025-05-15 | Chinese | |
| 2024年度内部控制审计报告 | 2025-04-25 | Chinese | |
| 关于2024年度证券投资与衍生品交易情况的专项说明 | 2025-04-25 | Chinese | |
| 第四届监事会第五次会议决议公告 | 2025-04-25 | Chinese | |
| 2024年度独立董事述职报告（于李胜） | 2025-04-25 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 38371760 | 国浩律师（深圳）事务所关于深圳华大基因股份有限公司二〇二四年年度股东会之法律意见书 | 2025-05-20 | Chinese | ||
| 38371743 | 关于召开2024年年度股东会的提示性公告 | 2025-05-15 | Chinese | ||
| 38371730 | 2024年度内部控制审计报告 | 2025-04-25 | Chinese | ||
| 38371718 | 关于2024年度证券投资与衍生品交易情况的专项说明 | 2025-04-25 | Chinese | ||
| 38371703 | 第四届监事会第五次会议决议公告 | 2025-04-25 | Chinese | ||
| 38371687 | 2024年度独立董事述职报告（于李胜） | 2025-04-25 | Chinese | ||
| 38371673 | 关于续聘2025年度审计机构的公告 | 2025-04-25 | Chinese | ||
| 38371656 | 2024年度监事会工作报告 | 2025-04-25 | Chinese | ||
| 38371638 | 2024年度内部控制评价报告 | 2025-04-25 | Chinese | ||
| 38371626 | 董事会审计委员会关于对会计师事务所2024年度履职情况评估及履行监督职责情况的报告 | 2025-04-25 | Chinese | ||
| 38371625 | 2024年度独立董事述职报告（曹亚已离任） | 2025-04-25 | Chinese | ||
| 38371608 | 2024年度募集资金存放与使用情况的专项报告 | 2025-04-25 | Chinese | ||
| 38371592 | 2024年度非经营性资金占用及其他关联资金往来情况的专项说明 | 2025-04-25 | Chinese | ||
| 38371572 | 关于2024年度计提信用减值损失、资产减值损失和核销资产的公告 | 2025-04-25 | Chinese | ||
| 38371558 | 中信证券股份有限公司关于深圳华大基因股份有限公司2024年度募集资金存放与使用情况的专项核查报告 | 2025-04-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BGI Genomics Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55655/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55655 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55655 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55655 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55655}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BGI Genomics Co., Ltd. (id: 55655)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.